newsfilter
← Latest News
PR Newswire·

MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation

R&D project on psilocybin's benefits in treating diseases of the brain VANCOUVER, BC, Nov. 30, 2021 /PRNewswire/ - MYND Life Sciences Inc. ("MYND" or the "Company") (CSE:MYND) (OTC:MYNDF) is pleased and extremely grateful to acknowledge the financ